Assessment of Predictive Role of Urodynamics in Sacral Neuromodulation Patients
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Universiteit Antwerpen
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Change in bladder sensation
Study Overview
Brief Summary
In the field of urology, sacral neuromodulation (SNM) is a well-accepted, second-line, minimally invasive treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with non-obstructive urinary retention (NOUR).
Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Overactive bladder
- •Non-obstructive urinary retention
Exclusion Criteria
- •Neurogenica disorder (e.g. cerebrovascular accident, spinal cord injury)
Outcomes
Primary Outcomes
Change in bladder sensation
Time Frame: 3 weeks
Bladder sensation is measured by a slider (indicating bladder fullness scaled from 0 to 100) before and after test procedure for sacral neuromodulation
Change in bladder volume
Time Frame: 3 weeks
Change in bladder volume is measured before and after test procedure for sacral neuromodulation
Change in ice water test
Time Frame: 3 weeks
Ice water is infused in the bladder and incontinence upon insertion of the ice water is assessed before and after sacral neuromodulation
Secondary Outcomes
No secondary outcomes reported
Investigators
Donald Vaganée
Principal Investigator
Universiteit Antwerpen